-
Loading metrics
Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation
- Lele Chang,
- Yaxin Kang,
- Mingxuan Zhu,
- Jing Liu,
- Chunyan Lan,
- Qin Xu
x
- Published: September 29, 2026
- https://doi.org/10.1371/journal.pone.0350571